Viatrexx-hair while Breastfeeding

What is Viatrexx-hair used for?

Is Viatrexx-hair usage safe while breastfeeding? If a lactating mother is using it can there be any effect on growth or development of infant?

Pantothenic acid while Breastfeeding

CAS Number: 79-83-4

Pantothenic acid, dexpanthenol or vitamin B5 is widely distributed in nature being very abundant in meat, vegetables, cereals, legumes, eggs, milk, fruit and vegetables (MedlinePlus 2015), therefore its deficiency is very rare. The only recognized indication for administering pantothenic acid is to treat vitamin B5 deficiency. There is no evidence that it can be used to treat any other disease or condition. (MedlinePlus 2015). Daily requirements are 2 mg in infants, 4 in children, 5 in adults, 6 in pregnant women and 7 mg in breastfeeding mothers (Ares 2015, MedlinePLus 2015). Pantothenic acid is excreted in breast milk at a concentration of 2 to 2.7 mg/L (Sakurai 2005, Song 1984) with little variation throughout breastfeeding (Ren 2015, Johnston 1981) and is directly proportional to maternal ingestion (Song 1984, Johnston 1981). The concentration is higher in milk of mothers of premature babies than in full-term infants (Ford 1983). With a varied and balanced diet, supplements of this vitamin are not needed during breastfeeding, it is enough to adequately select the food in one’s diet (Song 1985). Topical use, most commonly used as panthenol or provitamin B5, regardless of its questionable efficacy, is compatible with breastfeeding.

Biotin while Breastfeeding

CAS Number: 58-85-5

It is an essential co-enzyme for fat metabolism and other metabolic reactions, which is classified among the vitamin B group. Recommended daily allowance is 10 to 200 μg according to some authorities and 30 to 100 μg to some others. (5 at15 μg for infants, 20 to 30 μg for children, 30 μg for pregnant women and 35 μg for lactating mothers). Biotin is found in the non-fat fraction of breast milk in an amount of 5 to 9 μg/L. Biotin is widely distributed in most foods with a very rare occurrence of deficiency among people who are on adequate diet, nor any case of intoxication is known even with higher doses than recommended for daily intake. At date of latest update, relevant data related to breastfeeding were not found. However, because lack of toxicity a risk due to consumption at recommended dose is unlikely. With an adequate and comprehensive diet, the consumption of vitamin supplementation is not necessary.

Estradiol while Breastfeeding

CAS Number: 50-28-2

A natural Estrogen that is marketed for oral, injection and topical administration (skin and vaginal).On the chemical form of valerate, it is used in association with a progestin as a combined birth-control compound (e.g. Estradiol + Dienogest) Estradiol is excreted into breast milk in clinically non-significant amount (Nilson 1978) and no problems have been observed in infants whose mothers were treated (Pinheiro 2016). Plasma levels of these infants were undetectable or very low (Pinheiro 2016). After administration in the form of transdermal patches milk levels have been undetectable (Pinheiro 2016, Perheentupa 2004). Despite these data, an older publication associated the use of transdermal estradiol with a case of jaundice and poor weight gain (Ball 1999).There is greater passage to milk when the administration is vaginal. There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartumThey may reduce the protein content of the milk. No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. Estrogen exposure in childhood or adolescence, does not influence the subsequent production of milk. The American Academy of Pediatrics states that this medication is usually compatible with breastfeeding.

Estriol while Breastfeeding

Estrogenic drug for topical use with trophic effect on vaginal mucosa. While breastfeeding, non-hormonal lubricants (cream, jelly or ovules) are preferred agents for treatment of vaginal dryness due to hypo-estrogenic stimulation than those estrogenic-containing topical agents since their long lasting use may lowers breast-milk production.

Ginkgo while Breastfeeding

CAS Number: 90045-36-6

Leaves of tree are used.It contains flavonoids, tannins, diterpenes, steroids..Unproved effects: venous tonic, capillary protector, vasodilator (neuron-protector) and platelet anti-aggregationIndications after Commission E of German Ministry of Health: brain vascular insufficiency, intermittent claudication, dizziness, tinnitus. Fluids or solutions with alcoholic content are to be avoided.

Progesterone while Breastfeeding

CAS Number: 57-83-0

Excreted into breast milk in a non-significant amount with no side-effects observed in breastfed infants of treated mothers. The plasma levels in those infants have been undetectable or very low. During the first 6 weeks after birth, non-hormonal methods are of choice as contraceptives. If associated to estrogens may inhibit lactation. It is recommended the use of contraceptive medication that does not contain estrogens, or, better if it contains progestogen alone.

Saw palmetto while Breastfeeding

CAS Number: 84604-15-9

The fruits from this palm tree with a high content of fatty acids (oleic, lauric, myristic, linoleic and linolenic acids) are used. They also contain flavonoids and phytosterols (beta-sitosterol) that exert both an antiandrogenic and estrogenic action It is used for treatment of prostate hyperplasia. Also used, however on a poor scientific basis, for treatment of androgenic alopecia and hirsutism (Murugusundram 2009, Rossi 2012, Wessagowit 2016).. It has been related to some problems such as hormonal disruption when it was used in girls (Morabito 2015), but mostly without serious side effects (Agbabiaka 2009). At latest update no published data on excretion into breast milk were found. No likely risk when topically used, whenever it is not applied on the chest.A moderate consumption would not represent a risk while breastfeeding. It may be prudent to avoid using it during the neonatal period (within first month after birth) and in cases of prematurity. Cautions when taking herbal teas:1. Make sure it is obtained from a reliable source: reportedly, poisonings have occurred due to confusion after using another plant with toxic effects, some others contain heavy metals that may cause poisoning and others may cause food poisoning due to contamination with bacteria or fungi.2. Do not take it excessively. "Natural" products are not always good in any amount: plants contain active substances from which are made many compounds of our traditional pharmacopoeia that can cause poisoning if consumed in exaggerated quantities or for long periods.

Silicon dioxide while Breastfeeding

A polymer made out of silicon-oxygen-methyl combination with a high molecular weight, water repellent and low superficial tension. It is used in many ways (dimethicone, simethicone, -see specific items)orally to treat infant colic and flatulence; as pediculicide, in cosmetic creams and lotions and skin protectants as to prevent ulcers and scars; arthroplasties, retinal detachments and reconstruction or cosmetic surgery as injections and implants. Silicone is widely distributed in our environment with several cosmetic and medicinal uses. No evidence of toxicity on human tissues has been shown. A 1994 report on immunological side effects in infants breastfed by mothers with silicone implants, was denied categorically by means of meta-analysis and other work. The absorption by oral or dermal route is negligible. Both a high molecular weight and polymer molecular structure make it practically impossible excretion in the milk and hence a significant amount of intestinal absorption by the infant. Those circumstances make silicone implants safe for lactation even if broken or manufacturing fault (Poly Implant Prothèse, PIP). After extensive analysis of such silicone prosthesis, where lack of health risk was demonstrated, it can be concluded that many of the initial recommendations published lacked scientific validity, including that carriers of such prosthesis should not breastfeed. Silicon levels in blood and milk of women with implants (55 ng / ml) are similar to those of women without implants (51 ng / ml), 13 times lower than that found in cow's milk (709 ng / ml) and 80 times lower than in commercial infant formulas (4403 ng / ml). American Academy of Pediatrics: Product usually compatible with breastfeeding. To view other possible effects on breastfeeding of breast implant unrelated to silicone, see the term 'Augmentation Mammoplasty'. See below the information of these related products:

Zinc while Breastfeeding

Zinc (Zn) is an essential element for nutrition. It is present in many foods.Recommended daily allowance of Zn is 8 to 15 mg. (Moran Hall 2010). Millions of people worldwide are Zn-deficient.It is used as a treatment for Wilson's disease and Acrodermatitis Enteropathica. Zn is involved in the regulation process of lactation (Lee 2016).Pasteurization of the milk does not affect the concentration of Zn and other trace elements (Mohd Taufek-2016). The average concentration of Zn in breastmilk is 4 to 16 mg / L (Picciano 1976, Hannan 2005, Dórea 2012) which is independent of plasma levels and maternal daily intake (Krebs 1995, Chierici 1999, Hannan 2009).Intestinal absorption of zinc is almost doubled during pregnancy and lactation (Fung 1997).Zinc levels in the infant are dependent on Zinc levels in the breast milk (Dumrongwongsiri 2015)With a varied and balanced diet, an extra intake of minerals is not needed. Excessive intake of Zinc may cause gastrointestinal problems and Pancytopenia (Irving 2003).

Estradiol while Breastfeeding

CAS Number: 50-28-2

Limited information on the use of estradiol during breastfeeding indicates that the route of administration and dosage form have influences on the amount transferred into breastmilk. Vaginal administration results in measurable amounts in milk, but transdermal patches do not. Maternal doses of up to 200 mcg daily transdermally do not increase estradiol or estriol in breastfed infants or cause any adverse effects in breastfed infants. Vaginal administration results in unpredictable peak times for estradiol in breastmilk, so timing of the dose with respect to breastfeeding is probably not useful. A case report of inadequate milk production and inadequate infant weight gain was possibly caused by transdermal estradiol initiated on the first day postpartum, but 2 small studies found no such effect when the drug was initiated after lactation was well established.

Ginkgo while Breastfeeding

CAS Number: 90045-36-6

Ginkgo (Ginkgo biloba) leaf contains flavonoids (e.g., quercetin, kaempferol, isorhamnetine) and several terpene trilactones (e.g., ginkgolides, bilobalide) as well as numerous minor components. Standardization is based on ginkgo flavone glycoside and terpenoid content. Raw ginkgo seeds contain potentially toxic cyanogenic glycosides and should not be used; roasted seeds do not carry this risk. Ginkgo has no specific uses during breastfeeding, but is commonly used as an antioxidant, a vasodilator to increase cerebral and peripheral perfusion, and to improve memory. No data exist on the safety and efficacy of ginkgo in nursing mothers or infants. In general, it is well tolerated, but occasionally minor symptoms (e.g., headache, nausea, gastrointestinal complaints, allergic skin rashes) occur in those taking the drug. Ginkgo has caused some cases of bleeding in healthy volunteers caused by its antiplatelet activity. Because there is no published experience with ginkgo during breastfeeding, an alternate therapy may be preferred, especially while nursing a newborn or preterm infant.[1] Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.

Progesterone while Breastfeeding

CAS Number: 57-83-0

Release from the progesterone-releasing intrauterine device available in the United States is 65 mcg/day or only 0.65% of the dose released from most of the devices reported in the literature. Because of the low levels of progesterone in breastmilk, even with the high-dose products, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants. The progesterone vaginal ring available in some countries produces maternal blood levels that are lower than those of ovulating women.[1] Most studies indicate that progesterone is not detrimental to milk production or duration of nursing.[2][3] No special precautions appear to be required. In Russia, a progesterone gel (Progestogel - Besins Healthcare; not available in the US) has been used topically as a one-time application to the breasts to treat postpartum breast engorgement when more conservative measures have failed.[4] A subsequent study failed to detect any decrease in breast hardness 20 minutes after application of progesterone gel in mothers with engorgement.[5] The safety and efficacy of this use have not been well studied and the manufacturer of Progestogel recommends avoiding its use during lactation.

Thyroid, unspecified while Breastfeeding

CAS Number: 8028-36-2

Thyroid is an animal-derived mixture of levothyroxine (T4) and liothyronine (T3), which are normal components of human milk. Limited data on exogenous replacement doses of levothyroxine during breastfeeding indicate no adverse effects in infants. If thyroid is required by the mother, it is not a reason to discontinue breastfeeding. The American Thyroid Association recommends that subclinical and overt hypothyroidism should be treated with levothyroxine in lactating women seeking to breastfeed.[1] Thyroid dosage requirement may be increased in the postpartum period compared to prepregnancy requirements patients with Hashimoto's thyroiditis.[2]

Thyroid, unspecified and Breastfeeding

What if I already have used Viatrexx-hair?

I am nursing mother and my doctor has suggested me to use Viatrexx-hair, is it safe?

If I am using Viatrexx-hair, will my baby need extra monitoring?

Who can I talk to if I have questions about usage of Viatrexx-hair in breastfeeding?